EHTH vs BEAM vs EDIT vs GOCO

For growth investors, Beam Therapeutics Inc.

(BEAM) is the stronger pick with 120. 0% revenue growth year-over-year, versus -100. 0% for Editas Medicine, Inc. (EDIT). Analysts rate Beam Therapeutics Inc. (BEAM) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Beam Therapeutics Inc.

(BEAM) delivered a total return of -55. 6%, compared to -99. 4% for GoHealth, Inc. (GOCO). Over 10 years, the gap is even starker: BEAM returned +72. 4% versus GOCO's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), eHealth, Inc.

(EHTH) is the lower-risk stock at 2. 08β versus Editas Medicine, Inc. 's 2. 45β — meaning EDIT is approximately 18% more volatile than EHTH relative to the S&P 500. On balance sheet safety, eHealth, Inc. (EHTH) carries a lower debt/equity ratio of 14% versus 115% for GoHealth, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Beam Therapeutics Inc.

(BEAM) is pulling ahead at 120. 0% versus -100. 0% for Editas Medicine, Inc. (EDIT). On earnings-per-share growth, the picture is similar: GoHealth, Inc. grew EPS 90. 8% year-over-year, compared to 37. 5% for Editas Medicine, Inc.. Over a 3-year CAGR, BEAM leads at 31. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

eHealth, Inc.

(EHTH) is the more profitable company, earning 7. 2% net margin versus -57. 2% for Beam Therapeutics Inc. — meaning it keeps 7. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EHTH leads at 12. 4% versus -274. 6% for BEAM. At the gross margin level — before operating expenses — EHTH leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, EHTH (10.

4% yield) pays a dividend. BEAM, EDIT, GOCO do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, eHealth, Inc.

(EHTH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (10. 4% yield). GoHealth, Inc. (GOCO) carries a higher beta of 2. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EHTH: -85. 0%, GOCO: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (EHTH (Financial Services) and BEAM (Healthcare) and EDIT (Healthcare) and GOCO (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: EHTH is a small-cap income-oriented stock; BEAM is a small-cap high-growth stock; EDIT is a small-cap quality compounder stock; GOCO is a small-cap quality compounder stock. EHTH pays a dividend while BEAM, EDIT, GOCO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.